JP2023548590A5 - - Google Patents
Info
- Publication number
- JP2023548590A5 JP2023548590A5 JP2023527276A JP2023527276A JP2023548590A5 JP 2023548590 A5 JP2023548590 A5 JP 2023548590A5 JP 2023527276 A JP2023527276 A JP 2023527276A JP 2023527276 A JP2023527276 A JP 2023527276A JP 2023548590 A5 JP2023548590 A5 JP 2023548590A5
- Authority
- JP
- Japan
- Prior art keywords
- targeting agent
- subject
- sclc
- composition according
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063110664P | 2020-11-06 | 2020-11-06 | |
| US63/110,664 | 2020-11-06 | ||
| PCT/US2021/058218 WO2022098979A1 (en) | 2020-11-06 | 2021-11-05 | Methods and systems for classification and treatment of small cell lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548590A JP2023548590A (ja) | 2023-11-17 |
| JP2023548590A5 true JP2023548590A5 (https=) | 2024-11-12 |
Family
ID=81457377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527276A Pending JP2023548590A (ja) | 2020-11-06 | 2021-11-05 | 小細胞肺がんの分類と治療のための方法およびシステム |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230405117A1 (https=) |
| EP (1) | EP4240755A4 (https=) |
| JP (1) | JP2023548590A (https=) |
| KR (1) | KR20230104233A (https=) |
| CN (1) | CN116997572A (https=) |
| AU (1) | AU2021372988A1 (https=) |
| CA (1) | CA3200665A1 (https=) |
| WO (1) | WO2022098979A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4577578A1 (en) | 2022-08-22 | 2025-07-02 | Abdera Therapeutics Inc. | Dll3 binding molecules and uses thereof |
| CN116466089B (zh) * | 2023-04-27 | 2025-10-31 | 杭州华得森生物技术有限公司 | 采用微流控芯片与多重免疫荧光探针技术的基于sclc分子分型的ctc的检测试剂盒及其鉴定方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5117765B2 (ja) * | 2007-05-28 | 2013-01-16 | 国立大学法人 東京大学 | 抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤 |
| DK2530091T3 (en) * | 2010-01-29 | 2018-05-28 | Chugai Pharmaceutical Co Ltd | ANTI-DLL3 ANTIBODY |
| BR112014020826A8 (pt) * | 2012-02-24 | 2017-09-19 | Stem Centrx Inc | Anticorpo que se liga especificamente a um epítopo, ácido nucleico, vetor ou célula hospedeira, conjugado de fármaco anticorpo, composição farmacêutica compreendendo o referido anticorpo, uso do mesmo, kit e método de preparação do conjugado |
| MA41613A (fr) * | 2015-02-23 | 2018-01-02 | Abbvie Stemcentrx Llc | Récepteurs antigéniques chimériques anti-dll3 et procédés d'utilisation desdits récepteurs |
| TWI848953B (zh) * | 2018-06-09 | 2024-07-21 | 德商百靈佳殷格翰國際股份有限公司 | 針對癌症治療之多特異性結合蛋白 |
-
2021
- 2021-11-05 JP JP2023527276A patent/JP2023548590A/ja active Pending
- 2021-11-05 EP EP21890132.0A patent/EP4240755A4/en active Pending
- 2021-11-05 KR KR1020237018874A patent/KR20230104233A/ko active Pending
- 2021-11-05 CN CN202180088545.0A patent/CN116997572A/zh active Pending
- 2021-11-05 WO PCT/US2021/058218 patent/WO2022098979A1/en not_active Ceased
- 2021-11-05 AU AU2021372988A patent/AU2021372988A1/en active Pending
- 2021-11-05 US US18/252,005 patent/US20230405117A1/en active Pending
- 2021-11-05 CA CA3200665A patent/CA3200665A1/en active Pending